Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 3 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients.
Clin Transl Med. 2024 Mar;14(3):e1627. doi: 10.1002/ctm2.1627.
Clin Transl Med. 2024.
PMID: 38515274
Free PMC article.
Clinical Trial.
Mediator kinase inhibition reverses castration resistance of advanced prostate cancer.
Li J, Hilimire TA, Liu Y, Wang L, Liang J, Gyorffy B, Sikirzhytski V, Ji H, Zhang L, Cheng C, Ding X, Kerr KR, Dowling CE, Chumanevich AA, Mack ZT, Schools GP, Lim CU, Ellis L, Zi X, Porter DC, Broude EV, McInnes C, Wilding G, Lilly MB, Roninson IB, Chen M.
Li J, et al.
J Clin Invest. 2024 Mar 28;134(10):e176709. doi: 10.1172/JCI176709.
J Clin Invest. 2024.
PMID: 38546787
Free PMC article.
Item in Clipboard
Prostate cancer immunotherapy: a review of recent advancements with novel treatment methods and efficacy.
Wang I, Song L, Wang BY, Rezazadeh Kalebasty A, Uchio E, Zi X.
Wang I, et al.
Am J Clin Exp Urol. 2022 Aug 15;10(4):210-233. eCollection 2022.
Am J Clin Exp Urol. 2022.
PMID: 36051616
Free PMC article.
Review.
Item in Clipboard
Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer.
Kishore C, Zi X.
Kishore C, et al.
Curr Pharmacol Rep. 2023 Oct;9(5):261-274. doi: 10.1007/s40495-023-00333-z. Epub 2023 Sep 19.
Curr Pharmacol Rep. 2023.
PMID: 37994344
Free PMC article.
Item in Clipboard
ATPase Copper Transporting Beta (ATP7B) Is a Novel Target for Improving the Therapeutic Efficacy of Docetaxel by Disulfiram/Copper in Human Prostate Cancer.
Song L, Nguyen V, Xie J, Jia S, Chang CJ, Uchio E, Zi X.
Song L, et al.
Mol Cancer Ther. 2024 Jun 4;23(6):854-863. doi: 10.1158/1535-7163.MCT-23-0876.
Mol Cancer Ther. 2024.
PMID: 38417139
Item in Clipboard
Cite
Cite